HR =1.89, 95%CI [1.01–3.55] (p < 0.05), and 2.42 95%CI [1.11–5.31] (p = 0.03), respectively, as compared with patients whose tumor harbored EGFR exon 19 deletion. The gene discussed is EGFR; the disease is neoplasm.